SAN DIEGO, CA, UNITED STATES, February 9, 2026 / EINPresswire.com / — Present Moments Recovery, a family-owned San Diego alcohol & drug addiction treatment program, announced that they are now ...

"AtaiBeckley’s MDMA-based drug for anxiety shows benefit in Phase IIa trial" was originally created and published by Clinical ...

H contract; program targets major unmet need with no FDA-approved therapiesSAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company ...

The retrospective case study, which was supported by a research grant from Scripps Clinic Medical Group, included 30 patients who reduced their GLP-1 dose frequency for an average of 36 weeks.

SAN DIEGO COUNTY, Calif. — The drugs were stuffed inside a burrito, which a guard from the East Mesa Juvenile Detention Center had brought into the facility and dispersed to the youth inside. When a ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

San Diego photographer Jim Grant captured a video of a park ranger telling the family, who is visiting from China, to leave the sea lions alone.

Analysts consider AtaiBeckley’s MDMA candidate a “high-risk, high-reward” bet after the drug demonstrated reductions in ...

Onvuzosiran achieved significant and durable reductions of plasma kallikrein levels with a favorable safety profile in Phase 1/2 – SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, ...

Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder.